Chargement en cours...

New treatments for genotype 1 chronic hepatitis C – focus on simeprevir

Chronic hepatitis C virus (HCV) infection causes end-stage liver diseases and hepato cellular carcinoma. In the USA, Canada, and Japan, simeprevir – one of the second-generation HCV NS3/4A protease inhibitors – in combination with peginterferon α-2a or 2b plus ribavirin has recently been approved fo...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kanda, Tatsuo, Nakamoto, Shingo, Wu, Shuang, Yokosuka, Osamu
Format: Artigo
Langue:Inglês
Publié: Dove Medical Press 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4043814/
https://ncbi.nlm.nih.gov/pubmed/24920913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S50170
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!